Dissociation of the antimicrobial activity of bacitracin USP from its renovascular effects
- 1 May 1992
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 36 (5) , 955-961
- https://doi.org/10.1128/aac.36.5.955
Abstract
Bacitracin is a nephrotoxic antibiotic that has recently been shown to induce contractile effects in aortas isolated from rabbits by stimulating receptors for 5-hydroxytryptamine (5-HT). The possible renovascular actions of this antibiotic were investigated. Bacitracin USP increased the vascular resistance in a concentration-dependent manner (9 to 175 micrograms/ml) in rat kidneys perfused with a constant flow of Krebs solution. This was significantly inhibited by 5-HT antagonists, but only partially at the higher bacitracin concentration. An antagonist of the chemotactic peptide fMet-Leu-Phe failed to influence the pressor effect of bacitracin in rat kidneys. Indomethacin modestly reduced the effect of all potent pressor agents in the rat organ. Bacitracin USP was separated in several fractions by using C18 reverse-phase chromatography. Two distinct fractions were vasoconstrictive when infused in rat kidneys; both fractions were 5-HT mimetics. These peaks were different from the major antibiotic peak, bacitracin A, which was identified by using analytical high-pressure liquid chromatography, mass spectrometry, and inhibition of Micrococcus luteus growth. The less polar vasoactive peak corresponded to at least two minor peptides of the bacitracin family. The most abundant of these vasoactive peptides had no direct contractile effect on an aorta isolated from a rabbit, but a preliminary metabolic study in rat kidneys suggests that it is apparently transformed into a potent 5-HT agonist that is active on the aorta preparation. Bacitracin A, the major constituent of bacitracin with antimicrobial activity, had no vasoconstrictor effect in the test systems that we used; however, we did rule out the possibility that the renovascular stimulants found in the bacitracin mixture do not derive spontaneously or by biotransformation from the antibacterial forms of bacitracin.Keywords
This publication has 17 references indexed in Scilit:
- Bacitracin U.S.P. contains a factor that stimulates receptors for 5-hydroxytryptamine on rabbit aortic stripsLife Sciences, 1990
- Contractile effect of the chemotactic factors f-Met-Leu-Phe and C5a on the human isolated umbilical artery. Role of cyclooxygenase products and tissue macrophages.Circulation Research, 1990
- Selective inhibition of [3H]nitrendipine binding to brain and cardiac membranes by bacitracinCanadian Journal of Physiology and Pharmacology, 1989
- Improvement of chemical analysis of antibioticsJournal of Chromatography A, 1989
- Effect of Bacitracin and Polyamines on Follicle- Stimulating Hormone Binding to Membrane-Bound and Detergent-Solubilized Bovine Calf Testis Receptor*Endocrinology, 1983
- Studies on the inhibitory effect of bacitracin on 125I-labelled insulin internalization in the rat hepatocyteBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1983
- Determination of 5-hydroxytryptophan, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in 20 rat brain nuclei using liquid chromatography with electrochemical detectionCanadian Journal of Physiology and Pharmacology, 1983
- Action of serotonin (5-hydroxytryptamine) on cyclic nucleotides in glomeruli of rat renal cortexKidney International, 1979
- Cardiovascular actions of kinins in the rabbitCanadian Journal of Physiology and Pharmacology, 1979
- Antibiotics and peptides with agonist and antagonist chemotactic activityBiochemical and Biophysical Research Communications, 1978